Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2019, Article ID 3512706, 6 pages
https://doi.org/10.1155/2019/3512706
Case Report

Antepartum Diagnosis and Management of Lamin A/C Disease

1Center for Inherited Cardiovascular Disease, Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
2Maternal and Child Health Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
3Cardiac Electrophysiology Section, Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Correspondence should be addressed to Nosheen Reza; ude.nnepu.enicidemnnep@azer.neehson

Received 14 May 2019; Revised 24 September 2019; Accepted 11 October 2019; Published 11 November 2019

Academic Editor: Hajime Kataoka

Copyright © 2019 Nosheen Reza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Taylor, P. R. Fain, G. Sinagra et al., “Natural history of dilated cardiomyopathy due to lamin A/C gene mutations,” Journal of the American College of Cardiology, vol. 41, no. 5, pp. 771–780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Sylvius and F. Tesson, “Lamin A/C and cardiac diseases,” Current Opinion in Cardiology, vol. 21, no. 3, pp. 159–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. H. van Berlo, W. G. de Voogt, A. J. van der Kooi et al., “Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?” Journal of Molecular Medicine, vol. 83, no. 1, pp. 79–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Fu and H. J. Eisen, “Genetics of dilated cardiomyopathy,” Current Cardiology Reports, vol. 20, no. 11, 2018. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Kumar, S. H. Baldinger, E. Gandjbakhch et al., “Long-term arrhythmic and nonarrhythmic outcomes of lamin A/C mutation carriers,” Journal of the American College of Cardiology, vol. 68, no. 21, pp. 2299–2307, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. I. A. van Rijsingen, A. Bakker, D. Azim et al., “Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications,” International Journal of Cardiology, vol. 168, no. 1, pp. 472–477, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. I. A. W. van Rijsingen, E. Arbustini, P. M. Elliott et al., “Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study,” Journal of the American College of Cardiology, vol. 59, no. 5, pp. 493–500, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Meune, J. H. Van Berlo, F. Anselme, G. Bonne, Y. M. Pinto, and D. Duboc, “Primary prevention of sudden death in patients with lamin A/C gene mutations,” New England Journal of Medicine, vol. 354, no. 2, pp. 209-210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. G. Priori, C. Blomström-Lundqvist, A. Mazzanti et al., “2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC),” European Heart Journal, vol. 36, no. 41, pp. 2793–2867, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Kumar, A. F. A. Androulakis, J. M. Sellal et al., “Multicenter experience with catheter ablation for ventricular tachycardia in lamin A/C cardiomyopathy,” Circulation Arrhythmia and Electrophysiology, vol. 9, no. 8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. “A study of ARRY-371797 in patients with symptomatic dilated cardiomyopathy due to a lamin A/C gene mutation,” https://ClinicalTrials.gov/show/NCT03439514.
  12. C. MacIntyre, C. Iwuala, and R. Parkash, “Cardiac arrhythmias and pregnancy,” Current Treatment Options in Cardiovascular Medicine, vol. 20, no. 8, p. 63, 2018. View at Publisher · View at Google Scholar · View at Scopus
  13. V. R. Vaidya, S. Arora, N. Patel et al., “Burden of arrhythmia in pregnancy,” Circulation, vol. 135, no. 6, pp. 619–621, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Ertekin, I. M. van Hagen, A. M. Salam et al., “Ventricular tachyarrhythmia during pregnancy in women with heart disease: data from the ROPAC, a registry from the European Society of Cardiology,” International Journal of Cardiology, vol. 220, pp. 131–136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Palojoki, M. Kaartinen, R. Kaaja et al., “Pregnancy and childbirth in carriers of the lamin A/C‐gene mutation,” European Journal of Heart Failure, vol. 12, no. 6, pp. 630–633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. National Center for Biotechnology Information, ClinVar; [VCV000042540.4], United States National Library of Medicine, Bethesda, MD, USA, 2019, September 2019, https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000042540.4.
  17. T. J. Mathews and B. E. Hamilton, “Mean age of mothers is on the rise: United States 2000–2014,” in NCHS data brief, no 232, National Center for Health Statistics, Hyattsville, MD, 2016. View at Google Scholar